Evidence map›Paper›PMID 42696009›Full record

ArticleWorld journal of urology2026

Robot-assisted versus open kidney transplantation in patients who previously underwent an open kidney transplant.

Luca Afferi, Isacco Donnini, Andrea Gallioli, Begonya Etcheverry, Joris Vangeneugden, Jeremy Mercier, Angelo Territo, Thomas Prudhomme, Lorenzo Masieri, Alessio Pecoraro and 13 more

Abstract readComparative StudyMulticenter Study
In one paragraph

Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Luca AfferiDepartment of Surgery, Autonomous University of Barcelona, Barcelona, Spain. Luca.Afferi@autonoma.cat.
Isacco DonniniDepartment of Urology, Fundació Puigvert, Barcelona, Spain.
Andrea GallioliDepartment of Urology, Fundació Puigvert, Barcelona, Spain.
Begonya EtcheverryDepartment of Urology, Hospital Bellvitge, Bellvitge, Spain.
Joris VangeneugdenDepartment of Urology, Uz Gent, Gent, Belgium.
Jeremy MercierDepartment of Urology, Hospital of Toulouse, Toulouse, France.
Angelo TerritoDepartment of Urology, Fundació Puigvert, Barcelona, Spain.
Thomas PrudhommeDepartment of Urology, Hospital of Toulouse, Toulouse, France.
Lorenzo MasieriDepartment of Experimental and Clinical Medicine, University of Florence-Unit of Oncology, Florence, Italy.
Alessio PecoraroDepartment of Experimental and Clinical Medicine, University of Florence-Unit of Oncology, Florence, Italy.
Natalia Ortiz BenitezDepartment of Urology, Puerta del Mar University Hospital, Cadiz, Spain.
Rodrigo García-BaqueroDepartment of Urology, Puerta del Mar University Hospital, Cadiz, Spain.
Milla OrtvedUrological Research Unit, Department of Urology, Centre for Cancer and Organ Diseases, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
Malene RohrstedUrological Research Unit, Department of Urology, Centre for Cancer and Organ Diseases, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
Andreas RoderUrological Research Unit, Department of Urology, Centre for Cancer and Organ Diseases, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
Julia Abildgaard Dagnaes-HansenUrological Research Unit, Department of Urology, Centre for Cancer and Organ Diseases, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
Francesc ViguésDepartment of Urology, Hospital Bellvitge, Bellvitge, Spain.
Nicolas DoumercDepartment of Urology, Hospital of Toulouse, Toulouse, France.
Joan PalouDepartment of Surgery, Autonomous University of Barcelona, Barcelona, Spain.
Riccardo CampiDepartment of Experimental and Clinical Medicine, University of Florence-Unit of Oncology, Florence, Italy.
Sergio SerniDepartment of Experimental and Clinical Medicine, University of Florence-Unit of Oncology, Florence, Italy.
Karel DecaesteckerDepartment of Urology, Uz Gent, Gent, Belgium.
Alberto BredaDepartment of Surgery, Autonomous University of Barcelona, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

INTRODUCTION AND

objectivesThe safety of robot-assisted kidney transplantation (RAKT) in patients with end-stage renal disease (ESRD) who underwent an open kidney transplantation (OKT) in the past is unknown. We tested the hypothesis that intraoperative and postoperative complication rates are similar between RAKT and OKT in this patient population. MATERIALS AND

methodsThis was a multicenter retrospective cohort study including 78 patients with ESRD who received RAKT or OKT from living donor between 2015 and 2023 in 7 European academic centers. All patients had received an OKT in the past. The primary outcome was to assess perioperative safety in terms of intra- and postoperative complications, described using the Clavien-Dindo classification. Secondary outcomes included dialysis-free survival (DFS), surgical reintervention-free survival (RFS) and renal function at discharge. Kaplan Meier estimates and log-rank test were used to compare DFS and RFS according to the surgical approach.

resultsAmong 78 patients who previously underwent OKT, 29 (37%) patients subsequently underwent RAKT and 49 (63%) OKT. Patients' baseline characteristics were comparable between groups. The site of transplantation was the left iliac fossa in 24 (83%) and 30 (61%) patients undergoing RAKT and OKT, respectively (p = 0.07). Cold ischemia time was shorter in the RAKT group (60 vs. 114 min, p = 0.005), as was total vascular anastomosis time (33 vs. 38 min, p = 0.01). Estimated blood loss, rewarming time and intraoperative complications were similar in both groups. Early and late postoperative complications were similar in RAKT and OKT (respectively: 17% vs. 33%, p = 0.1; and 14% vs. 10%, p = 0.7). Over a median follow-up of 42 (IQR: 20-74) months, DFS was similar between RAKT and OKT, whereas RFS was higher in the RAKT group (100% vs. 84%, p = 0.02). Main limitations are represented by patient selection and the small sample size.

conclusionsIn selected patients undergoing kidney re-transplantation after a previous OKT, RAKT appears to be technically feasible and provides perioperative outcomes comparable to the open approach. In this challenging surgical setting, RAKT may represent a valuable option in experienced centres.

Indexed as

Intraoperative ComplicationsKidney Failure, ChronicKidney TransplantationPostoperative ComplicationsRobotic Surgical ProceduresAdultFemaleHumansMaleMiddle AgedRetrospective StudiesLiving donorsOKTOpen kidney transplantationRAKTRobot-assisted kidney transplantation

Identifiers

PMID42696009
PMCPMC13545120

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.